José Castillo Selected Research

José Castillo Research Topics

Disease

84	Stroke (Strokes) 03/2024 - 04/2002
68	Ischemic Stroke 03/2024 - 08/2002
28	Brain Ischemia (Cerebral Ischemia) 01/2022 - 01/2003
27	Inflammation (Inflammations) 01/2023 - 10/2005
26	Infarction (Infarctions) 01/2019 - 10/2002
16	Ischemia 10/2018 - 01/2003
9	Brain Injuries (Brain Injury) 01/2018 - 10/2002
7	Hematoma 07/2021 - 01/2007
7	Cerebral Hemorrhage 12/2020 - 07/2003
7	Migraine Disorders (Migraine) 03/2020 - 05/2007
6	Necrosis 02/2024 - 10/2002
6	Periodontitis 11/2023 - 01/2019
6	Embolic Stroke 01/2022 - 08/2012
6	Cerebral Infarction 01/2021 - 01/2003
5	Leukoaraiosis 02/2024 - 10/2010
5	Lacunar Stroke 01/2019 - 05/2002
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2018 - 10/2002
4	Hypothermia 01/2020 - 09/2005
4	Atherosclerosis 09/2016 - 06/2012
4	Edema (Dropsy) 01/2013 - 01/2007
4	Brain Edema (Cerebral Edema) 12/2012 - 09/2005
4	Hypertension (High Blood Pressure) 07/2009 - 05/2002
3	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 03/2019
3	Hyperthermia 07/2020 - 03/2003
3	Hemorrhage 06/2017 - 07/2004
2	Obesity 02/2022 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 03/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2020
2	Atrial Fibrillation 01/2019 - 07/2013
2	Iron Overload 01/2018 - 01/2007
2	Transient Ischemic Attack 01/2017 - 08/2013
2	Asphyxia (Suffocation) 01/2017 - 01/2016
2	Hyperglycemia 10/2010 - 03/2003
2	Headache (Headaches) 05/2007 - 10/2005

Drug/Important Bio-Agent (IBA)

31	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2005
25	Glutamic Acid (Glutamate)FDA Link 06/2022 - 10/2002
21	Interleukin-6 (Interleukin 6)IBA 06/2022 - 04/2002
15	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2024 - 01/2003
14	Neuroprotective AgentsIBA 01/2022 - 12/2002
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 11/2023 - 07/2003
9	EnzymesIBA 01/2022 - 01/2003
9	Oxaloacetic Acid (Oxalacetic Acid)IBA 01/2017 - 06/2011
8	Cytidine Diphosphate Choline (Citicoline)IBA 08/2016 - 12/2002
7	Transaminases (Aminotransferases)IBA 01/2017 - 06/2011
6	Fibronectins (Fibronectin)IBA 11/2020 - 07/2004
6	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2020 - 01/2003
6	IronIBA 01/2020 - 10/2002
6	erucylphosphocholineIBA 04/2017 - 10/2007
5	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 01/2009
5	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 03/2005
5	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 06/2013 - 06/2007
5	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2012 - 01/2009
4	C-Reactive ProteinIBA 06/2022 - 06/2012
4	InterleukinsIBA 02/2022 - 03/2003
4	Therapeutic UsesIBA 01/2022 - 02/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2009
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 01/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012 - 08/2003
4	CytokinesIBA 06/2008 - 05/2002
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2024 - 02/2011
3	Endothelin-1 (Endothelin 1)IBA 01/2023 - 07/2008
3	AnticoagulantsIBA 01/2022 - 01/2003
3	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 01/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 06/2007
3	Peptides (Polypeptides)IBA 01/2020 - 12/2017
3	Oxygen (Dioxygen)IBA 10/2018 - 03/2005
3	Interleukin-10 (Interleukin 10)IBA 01/2018 - 03/2003
3	NeuroserpinIBA 05/2011 - 02/2011
3	Antihypertensive Agents (Antihypertensives)IBA 07/2009 - 02/2004
2	Contrast MediaIBA 10/2022 - 03/2019
2	Fibrinogen (Factor I)FDA Link 06/2022 - 01/2005
2	LeptinIBA 02/2022 - 01/2018
2	AdiponectinIBA 02/2022 - 01/2018
2	CeramidesIBA 01/2022 - 01/2021
2	SphingolipidsIBA 01/2022 - 01/2021
2	LipidsIBA 01/2021 - 09/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 01/2018
2	PTX3 proteinIBA 03/2020 - 01/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 12/2009
2	Amyloid beta-PeptidesIBA 01/2020 - 03/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 03/2015
2	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 05/2015
2	Collagenases (Collagenase)FDA Link 10/2018 - 07/2015
2	Natriuretic PeptidesIBA 12/2017 - 05/2015
2	HaptoglobinsIBA 06/2012 - 08/2009
2	Excitatory Amino Acid AntagonistsIBA 02/2012 - 03/2006
2	Transcription Factors (Transcription Factor)IBA 03/2010 - 01/2008
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2008 - 08/2002
2	Ferritins (Ferritin)IBA 01/2008 - 01/2007
2	ProstaglandinsIBA 02/2006 - 06/2005
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2005 - 08/2003
2	Adenosine Triphosphate (ATP)IBA 03/2005 - 03/2005

Therapy/Procedure

33	Therapeutics 03/2024 - 09/2005
5	Thrombolytic Therapy 01/2021 - 01/2003
4	Secondary Prevention 01/2020 - 05/2012
3	Aftercare (After-Treatment) 06/2007 - 07/2004
2	Low-Level Light Therapy (LLLT) 09/2020 - 01/2019
2	Injections 04/2020 - 01/2012
2	Immunomodulation 01/2009 - 01/2008